Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents
about
Synthesis and cytotoxic activity of pentacyclic triterpenoid sulfamates.Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinones.Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors.A 2-methoxyestradiol bis-sulphamoylated derivative induces apoptosis in breast cell linesSteroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors.The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX ExpressionBCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptors.Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.17-beta-estradiol analog inhibits cell proliferation by induction of apoptosis in breast cell lines.2-Methoxyestradiol-bis-sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell lineTubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures.Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations.
P2860
Q30316859-5DE6404C-6D2A-481D-B8AF-16B023E8D91DQ33967160-2ECA9464-45E7-48AC-84C1-CE0016C3AEF7Q34094248-B809A36B-8688-4C0A-B2CA-CE11583CADABQ35530707-51D35DE4-FC00-4991-8B51-03D24292A1C7Q35668980-9E5C7AD1-CB97-4781-9955-1F84EEB2AD19Q36134768-3A6FD30A-DAC6-46DE-9227-7937F07B6827Q37135243-C6D36F04-9C5B-44DC-8617-763602F46D59Q37423480-946E02C4-9FA4-48C1-BF57-80D63F5015A6Q37507823-1E94110F-471F-47BD-BA48-C11C19C40C2BQ39032020-1D4FB700-D4E6-4901-8916-3F559398C5BFQ39294617-2D4D41B7-3A2B-4C13-9018-8BA31439C832Q47773650-BB3901A4-610F-4675-B552-B4A492CB053EQ52565862-E7BB1859-6457-4BF6-8E5B-F5155F067855
P2860
Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Structure-activity relationshi ...... ratrienes as anticancer agents
@ast
Structure-activity relationshi ...... ratrienes as anticancer agents
@en
Structure-activity relationshi ...... ratrienes as anticancer agents
@nl
type
label
Structure-activity relationshi ...... ratrienes as anticancer agents
@ast
Structure-activity relationshi ...... ratrienes as anticancer agents
@en
Structure-activity relationshi ...... ratrienes as anticancer agents
@nl
prefLabel
Structure-activity relationshi ...... ratrienes as anticancer agents
@ast
Structure-activity relationshi ...... ratrienes as anticancer agents
@en
Structure-activity relationshi ...... ratrienes as anticancer agents
@nl
P2093
P50
P356
P1476
Structure-activity relationshi ...... ratrienes as anticancer agents
@en
P2093
Atul Purohit
Barry V L Potter
Chloe Stengel
Eric Ferrandis
Fabrice L Jourdan
Keira Gaukroger
Mary F Mahon
Mathew P Leese
Michael J Reed
Sandra Regis-Lydi
P304
P356
10.1021/JM701319C
P407
P577
2008-03-13T00:00:00Z